Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team
Regulatory press release

PAXMAN receives orders for 16 scalp cooling systems to the UK and 10 systems to Italy

Paxman
Download the release

PAXMAN announces that the company is noticing a continued strong order flow in Europe in the beginning of 2020, from new customers as well as from cancer centres in the UK preparing to upgrade their older systems. The company recently received an order for 16 systems for the prestigious Royal Marsden NHS Foundation Trust in the UK, and an order for 10 systems to the company’s distributor in Italy.

Leading cancer research and treatment since 1851, The Royal Marsden was the world’s first hospital dedicated to cancer diagnosis, treatment, research and education. Today, ranking in the top five cancer centres in the world for the impact of their research, The Royal Marsden operates from two centres in Chelsea and Sutton, along with a Medical Day Care Unit at Kingston Hospital.

The 16 systems in this order, together with three previously ordered systems, will be used to upgrade The Royal Marsden’s older PAXMAN systems. All of the 16 systems are delivered with capacity for two simultaneous users.

Thanks to The Royal Marsden Cancer Charity, which raises money solely to support The Royal Marsden, patients at The Royal Marsden are set to benefit from these 16 new Scalp Cooling Systems across their hospital sites.

The 10 systems for Italy will be delivered to PAXMAN’s distributor PRAESIDIA s.r.l. and will be used to build stock in anticipation of expected upcoming orders.

“It is exciting to be able to start 2020 with a strong order flow in Europe from both existing and new customers. The Royal Marsden is a cancer centre with broad expertise, and we look forward to continue offering market-leading scalp cooling from PAXMAN together with them for many years to come”, says PAXMAN’s CEO Richard Paxman.

Contacts


Richard Paxman, CEO
Tel: +44 7968 020641
Email: richard@paxmanscalpcooling.com
www.paxman.se

About Us


The Paxman Scalp Cooling System has been developed by the Paxman family to reduce hair loss in breast cancer patients undergoing chemotherapy. The concept behind the system came when the mother of four, Sue Paxman, experienced first-hand the trauma of chemotherapy-induced hair loss. With close to 3,500 systems delivered in to hospitals, clinics and treatment centres around the world, PAXMAN is the leading supplier of Scalp Cooling technology. PAXMAN’s scalp-cooling cap is made from lightweight, biocompatible silicone that is soft and flexible, providing a snug yet comfortable fit during treatment. PAXMAN AB (publ) has its headquarters in Karlshamn (Sweden), with subsidiaries in Huddersfield (UK) and Houston, Texas (US).

The PAXMAN share is listed on Nasdaq First North Growth Market. FNCA Sweden AB is the company’s Certified Adviser and can be contacted via info@fnca.se and +46 (0)8 528 003 99.

Attachments


PAXMAN receives orders for 16 scalp cooling systems to the UK and 10 systems to Italy

Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.